Friday File, Part Two: Grant’s Conference Notes
I watched the Grant’s Interest Rate Observer Conference this week via webcast, and it continues to be one of my favorite events — though I’d rather be there in person. These are some of my notes about...
View ArticleFriday File, Part One: Fairfax, Columbia, IIPR and some Random Thoughts
A few thoughts to share with you today, and I’m breaking it up into two different pieces — this first one includes a few updates on companies and a couple articles that caught my eye this week… and the...
View ArticleInfinite Income
Dividend-focused stock picking newsletter launched in 2018, Burnick previously worked on a variety of other newsletters from other publishers, most recently Real Wealth Report at Weiss Research.
View ArticleWhat are “Trump Bonus Checks?”
You know, I expect, that there’s no secret trove of “programs” where you can “sign up” and get a free check in the mail every month. But still, the notion that there’s “hidden income” out there is...
View Article“Assassin’s Mace” and China’s Master Plan for the South China Sea
This article was originally published on January 25, 2017. It has not been updated or revised since then, but we are seeing the same ad from Dr. Moors circulating heavily again (still with a January...
View ArticleLichtenfeld’s “Killer Hiding in Your Medicine Cabinet”— what’s the “new...
The beginning of the latest ad from Marc Lichtenfeld’s Lightning Trend Trader is good and juicy, at the very least… how could you not open up the ad and pay attention? “The KILLER Hiding in Your...
View ArticleCabot’s “Already Growing its Earnings 81 Times Faster than Amazon” Stock
This is a quickie, dear friends, because, well, it’s a teaser pitch we’ve covered before. But I thought it worthwhile to take another quick look — and not just because I actually own the stock (though...
View ArticleReviewing Curzio’s “This Tiny $6 Company is Going to Replace Every ‘Smart...
This article was originally published on March 26, with an immediate deadline at the time… but the ad is now being recirculated by Marin Katusa with a new April 30 deadline, so we’re re-sharing the...
View ArticleFriday File Part One: Visit to the Thawing North, and a Few Buys (and sells)
It was a little ugly to go from frolicking on the Florida beaches with the Little Gumshoes to wandering the cold and rainy streets of Toronto, but my trip to the Fairfax Financial Annual Meeting was...
View ArticleFriday File Part Two – Portfolio News and Updates (GOOG, SPACs, IQ, FB, INTC,...
Plenty has happened in the past week or so, as I’ve been on the road (both vacationing in the sun and working in the rain), so what’s up with the Real Money Portfolio? On the news front we’ve gotten a...
View ArticleCasey’s “5 Tiny ‘Pot’ Stocks Set to Soar in 2018 Pot Boom” teased in “Become...
This article was originally published on January 11, but the Casey folks are promoting these same five stocks quite similarly with the bait of their “Become a Marijuana Millionaire in 2018” report,...
View ArticleFriday File, Part Three: India (Fairfax India and Graham Value Conference...
Fairfax India Holdings (FIH-U.TO, FFXDF) is a separate investment fund controlled (and about 1/3 owned) by Fairfax Financial (FFH.TO, FRFHF). For those unfamiliar, it was started because Fairfax wanted...
View ArticleGraham Centre Value Investing Conference: Buying “Value” in Real Estate
William McMorrow of Kennedy-Wilson spoke at the conference with a talk called, “lessons learned from 30 years of real estate value investing.” This is a company I’ve been keeping an eye on for a while,...
View Article“The One Tech Stock to Buy and Never Sell!”
What’s Moe Zulfiqar pitching as “The one tech stock to buy and never sell?” I’ve seen a couple versions of this teaser ad come rolling into Gumshoe HQ over the past week or so, and it’s time for a...
View ArticleCabot says “$38 Biotech Doubler to Hit $80: Buy Now”— what is it?
Here’s what got some Gumshoe readers’ attention in the latest ad from Cabot Small Cap Confidential: “The $1.3 billion medical device company I’m about to name will soon be an $80 stock that you must...
View ArticleOK, OK, We’ll tell you about Crypto Pot!
The number of questions about this one is going off the charts, so I’ll look into it for you — even though it’s related to not one but two bubblicious sectors that are designed for the manipulation of...
View ArticleFriday File Unlocked: Kent Moors’ $2 Million Startup and $7 Trillion Energy...
This article originally ran as part of the Friday File for the Irregulars on January 12. It has not been updated or revised since then, though I’ve left the original reader comments appended and have...
View ArticleFriday File: Two Sell/Buy Simplifications in Mining, plus more Buffett, a...
We’ve seen a long stream of earnings reports and other worthwhile bits of data on Real Money Portfolio stocks since I last wrote to you, including some that actually included some interesting news, so...
View ArticleWealth Eruption
Small cap advisory for Australia-listed stocks, launched early in 2019.
View Article“The ‘Everything App’ Goes VIRAL” teases huge growth for Aussie stock
I’ve gotten several messages from Australia over the past few days about a promo that’s headlined “The Everything App”, and it does catch the eye… not least because they’re talking up a five-cent...
View Article